Cancer Waiting Times, UK countries   England Wales Scotland

Slides:



Advertisements
Similar presentations
Breast Cancer (C50): 2014 Number of New Cases, Crude and European Age-Standardised (AS) Incidence Rates per 100,000 Population, UK Northern England Wales.
Advertisements

(cervical cancer only)
Mesothelioma (C45): 2014 Number of New Cases, Crude and European Age-Standardised (AS) Incidence Rates per 100,000 Population, UK Northern England Wales.
Eye Cancer (C69): 2014 Number of New Cases, Crude and European Age-Standardised (AS) Incidence Rates per 100,000 Population, UK Northern England Wales.
Sarcoma: Cancer Waiting Times, UK countries England Wales
Uterine Cancer (C54-C55): 2014 Number of New Cases, Crude and European Age-Standardised (AS) Incidence Rates per 100,000 Population, Females, UK Northern.
Cancer of Unknown Primary (C77-C80): 2013
Head & Neck Cancer (C00-C14, C30-C32): 2014
Haematological Cancers:
Bone Cancer (C40-C41): 2014 Cancer Patient Experience Survey, by Sex, England Female Male Persons Percentage of 53.4% 50.0% 51.7% patients treated for.
Prostate Cancer (C61): 2014 Number of New Cases, Crude and European Age-Standardised (AS) Incidence Rates per 100,000 Population, Males, UK Northern England.
Liver Cancer (C22): 2014 Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, UK Northern England Wales Scotland.
Cervical Cancer (C53): 2014 Cancer Patient Experience Survey, by Sex, England Female Percentage of 62.9% patients treated for cancer who visited their.
(testicular cancer ony)
Upper Gastrointestinal Cancers:
Breast Cancer (C50): 2014 Cancer Patient Experience Survey, by Sex, England Female Male Persons Percentage of 87.5% 83.3% 87.4% patients treated for cancer.
Lung Cancers: Cancer Waiting Times, UK countries England
Cancer Waiting Times, UK countries   England Wales Scotland
Selected Common Cancers, Percentage Change in European Age-Standardised Mortality Rates, Females, UK, *Brain and central nervous system (CNS)
Brain, Other CNS and Intracranial Tumours (C70-C72, C75. 1-C75
Age-Standardised Ten-Year Net Survival for the Most Common Cancers in Males, England and Wales, Ten-year survival for is predicted.
Uterine Cancer (C54-C55): 2014 Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, Females, UK Northern.
In Situ Breast Carcinoma (D05): 2014
Lower Gastrointestinal Cancers:
Age-Standardised Ten-Year Net Survival for the Most Common Cancers in Females, England and Wales, Ten-year survival for is predicted.
Selected Common Cancers, Percentage Change in European Age-Standardised Mortality Rates, Persons, UK, *Brain and central nervous system (CNS)
Breast Cancer: Cancer Waiting Times, UK countries
Non-Melanoma Skin Cancer (C44): 2014
Stomach Cancer (C16): 2014 Cancer Patient Experience Survey, by Sex, England Female Male Persons Percentage of 39.0% 51.7% 48.0% patients treated for cancer.
Lung Cancer (C33-C34): 2014 Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, UK Northern England Wales.
Kidney Cancer (C64-C66,C68): 2014 Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, UK Northern England.
Bone Sarcoma (C40-C41): 2014 Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, UK Northern England Wales.
per 100,000 Population, Females, UK
Liver Cancer (C22): 2014 Cancer Patient Experience Survey, by Sex, England Female Male Persons Percentage of 42.2% 57.1% 52.8% patients treated for cancer.
Ovarian Cancer (C56-C57.4): 2014 Cancer Patient Experience Survey, Females, England Female Percentage of 47.0% patients treated for cancer who visited.
Eye Cancer (C69): 2014 Cancer Patient Experience Survey, by Sex, England Female Male Persons Percentage of 86.4% 76.6% 80.9% patients treated for cancer.
Malignant Melanoma (C43): 2014
Chronic Myeloid Leukaemia (C92.1): 2014
Oral Cancer (C00-C06,C09-C10,C12-C14): 2014
Hodgkin Lymphoma (C81): 2014 Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, UK Northern England Wales.
Bowel Cancer (C18-C20): 2014 Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, UK Northern England Wales.
Oesophageal Cancer (C15): 2014
Non-Hodgkin Lymphoma (C82-C86): 2014
Myeloma (C90): 2014 Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, UK Northern England Wales Scotland.
Chronic Lymphocytic Leukaemia (C91.1): 2014
Lung Cancer (C33-C34): 2014 Cancer Patient Experience Survey, by Sex, England Female Male Persons Percentage of 50.3% 51.4% 50.9% patients treated for.
Prostate Cancer (C61): 2014 Cancer Patient Experience Survey, Males, England Male Percentage of 51.9% patients treated for cancer who visited their GP.
Acute Myeloid Leukaemia (C92. 0, C92. 4, C92. 5, C92. 6, C92. 8, C93
Penile Cancer (C60): 2014 Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, Males, UK Northern England.
Bladder Cancer (C67): 2014 Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, UK Northern England Wales.
Anal Cancer (C21): 2014 Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, UK Northern England Wales Scotland.
Pancreatic Cancer (C25): 2014
per 100,000 Population, Females, UK
Eye Cancer (C69): 2014 Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, UK Northern England Wales Scotland.
Age-Standardised One-, Five- and Ten-Year Net Survival, Selected Cancers, Adults (Aged 15-99), England and Wales, Five- and ten-year survival.
Leukaemia (C91-C95): 2014 Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, UK Northern England Wales.
Acute Lymphoblastic Leukaemia (C91.0): 2014
Prostate Cancer (C61): 2014 Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, Males, UK Northern England.
Gallbladder Cancer (C23): 2014
Cancer of Unknown Primary (C77-C80): 2014
Acute leukaemia: Cancer Waiting Times, UK countries England
Ovarian Cancer (C56-C57.4): 2014 Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, Females, UK Northern.
The Three Most Common Cancers: 2013
Breast Cancer (C50): 2014 Numbers of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, UK Northern England Scotland.
Stomach Cancer (C16): 2014 Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, UK Northern England Wales.
Thyroid Cancer (C73): 2014 Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, UK Northern England Wales.
Laryngeal Cancer (C32): 2014 Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, UK Northern England Wales.
Haematological Cancers:
Brain, Other CNS and Intracranial Tumours (C70-C72, C75. 1-C75
Brain, Other CNS and Intracranial Tumours (C70-C72, C75. 1-C75
Presentation transcript:

Head and Neck Cancers: 2014-2015 Cancer Waiting Times, UK countries   England Wales Scotland Northern Ireland 14 day wait: seen by specialist following referral Performance 95.7% Standard 93% Performance against standard Meets standard 31 day wait: receipt of first treatment following decision to treat 97.2% 96.0% 96.4% 98% 95% Does not meet standard 62 day wait: receipt of first treatment following referral 74.5% 89.7% 60.0% Data not available for 14 day wait in Wales, Scotland or NI. Data not available for 31 or 62 day wait in England. Codes vary per country but cancer waiting times data group 'Head and Neck cancers' broadly includes: Lip, tongue, gum, floor of mouth, palate, other and unspecified parts of mouth, parotid gland, salivary glands, tonsil, oropharynx, nasopharynx, piriform sinus, hypopharynx, other ill-defined site of lip, oral cavity and pharynx, nasal cavity and middle ear, accessory sinuses, larynx, thyroid and lymph nodes and other and ill-defined sites of the head, face and neck. See source for more information. Source: cruk.org/cancerstats You are welcome to reuse this Cancer Research UK statistics content for your own work. Credit us as authors by referencing Cancer Research UK as the primary source. Suggested style: Cancer Research UK, full URL of the page, Accessed [month] [year].